A patient with depression and a history of bulimia nervosa is being considered for an atypical antidepressant. Which agent should be avoided and why?
Choose an answer, then check it.
Clinical Pharmacology · Antidepressants
Atypical Antidepressants
On this page 6 sections
In 30 seconds
Atypical antidepressants are the drugs that don't fit the SSRI, SNRI, TCA, or MAOI molds, and each earns its place through a mechanism suited to a specific clinical problem rather than as a universal first choice. Bupropion adds energy and spares sexual function; mirtazapine and trazodone trade sedation and appetite stimulation for help with sleep; vilazodone and vortioxetine modulate serotonin with gentler sexual side effects than SSRIs; and ketamine/esketamine act within hours for treatment-resistant depression. Choosing among them is really an exercise in matching a drug's side-effect profile, and sometimes a comorbidity, to the patient in front of you.
The college version
Bupropion: stimulating and weight-neutral
Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) with no direct serotonergic activity. Because it does not raise synaptic serotonin, it is largely free of the sexual dysfunction, weight gain, and sedation common with SSRIs and TCAs; it suits patients with low energy or a history of SSRI-related sexual side effects, and it is also approved for smoking cessation. Its defining safety concern is a dose-dependent lowering of the seizure threshold, making it contraindicated in seizure disorders and in current or past bulimia or anorexia nervosa, where purging and electrolyte disturbances further raise seizure risk. Being activating, it is generally avoided in significant anxiety or insomnia.
Mirtazapine: sedation and appetite as a feature
Mirtazapine blocks presynaptic alpha-2 autoreceptors, increasing norepinephrine and serotonin release, while antagonizing postsynaptic 5-HT2 and 5-HT3 receptors. This blockade largely eliminates the sexual dysfunction and nausea seen with serotonergic drugs, while potent histamine (H1) blockade produces marked sedation and appetite stimulation. These are often the reason it is chosen, not side effects to avoid: it suits patients with insomnia or significant weight loss, including older adults and cancer patients. Teaching covers dosing at night, expected weight gain, and rare agranulocytosis warranting attention to unexplained fever.
Trazodone: an off-label sleep aid
Trazodone is a serotonin antagonist/reuptake inhibitor (SARI) that blocks serotonin reuptake and 5-HT2A receptors; at the low exposure used clinically today, its antihistamine and alpha-1 blocking effects dominate, producing sedation without TCA-level anticholinergic burden. This makes it a common off-label choice for insomnia, including alongside an SSRI or SNRI. Its most urgent rare adverse effect is priapism, a persistent, painful erection unrelated to arousal that is a urologic emergency requiring immediate care to prevent permanent tissue damage; patients should be taught to seek care right away, not wait it out. Orthostatic hypotension is another key teaching point.
Vilazodone and vortioxetine: refined serotonin modulators
Vilazodone combines serotonin reuptake inhibition with partial agonism at 5-HT1A receptors, while vortioxetine combines reuptake inhibition with modulation of other serotonin receptor subtypes. Both aim to preserve efficacy while reducing sexual dysfunction versus standard SSRIs, and vortioxetine is also linked to modest benefit for cognitive symptoms. Both still carry class-wide serotonergic risks, including serotonin syndrome with other serotonergic or MAOI agents, and early nausea is common.
Ketamine, esketamine, and neurosteroid options: rapid-acting agents
Ketamine and its enantiomer esketamine act as NMDA receptor antagonists, distinct from monoamine reuptake inhibition, producing antidepressant effects within hours rather than the weeks typical of standard agents. They are reserved for treatment-resistant depression or acute suicidal ideation, given only in a certified, monitored setting because of dissociative effects, transient blood pressure elevation, and abuse potential; patients are observed afterward and cannot drive themselves home. Newer neurosteroid options act on GABA-A receptors, another rapid mechanism, also used under structured monitoring. The theme across this class: an agent is chosen because its mechanism, speed, or side-effect profile answers a specific need — energy versus sedation, weight neutrality versus appetite gain, fewer sexual side effects, or a treatment-resistant emergency.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Think of antidepressants as tools in a toolbox. Most (SSRIs, SNRIs, TCAs, MAOIs) work like different sizes of the same wrench. The "atypical" ones are oddball tools that each do something special. Bupropion is like a cup of coffee — it perks you up and doesn't make you sleepy or hungry, but you shouldn't use it if you're prone to seizures. Mirtazapine and trazodone are like a warm blanket — they make you sleepy and hungrier, which sounds bad, but if you're not sleeping or eating enough, that's exactly the help you need. Vilazodone and vortioxetine are smoother, more polished versions of the standard tools with fewer annoying side effects. Ketamine is the emergency tool: it can work in hours instead of weeks, but only under close medical supervision.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient with depression, insomnia, and significant unintentional weight loss asks why the provider chose mirtazapine instead of an SSRI. What clinical reasoning explains this choice?
Show answer
Mirtazapine's sedating and appetite-stimulating side effects directly counter this patient's insomnia and weight loss
Because mirtazapine's histamine and serotonin receptor blockade cause sleepiness and increased appetite, side effects usually seen as unwanted become therapeutic here, addressing two specific symptoms alongside the depression itself.
A patient with severe, treatment-resistant depression and active suicidal ideation is being evaluated for esketamine. What administration requirement distinguishes this drug from typical oral antidepressants, and why does it matter?
Show answer
Esketamine must be given in a certified, monitored setting with a required observation period afterward, due to dissociative effects, blood pressure changes, and abuse potential
Unlike a pill taken at home, esketamine can briefly alter perception and raise blood pressure, so staff must watch the patient for a set time after dosing and ensure they do not drive themselves home, protecting safety during its short but intense window of action.
Quick check
3 questions here. Answers stay hidden until you check.
Which mechanism best describes mirtazapine's therapeutic effect on sleep and appetite?
Choose an answer, then check it.
A patient taking trazodone for sleep reports a persistent, painful erection lasting several hours. What is the appropriate response?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.